Marino Stram & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
FWIA
GAM
SRIM
DC
Marino Stram & Associates's MDT Position: Q2 2026 in Review
Marino Stram & Associates reduced its Medtronic (MDT) stake by 4.1% in Q2 2026, selling an estimated $21.1K and leaving 6,113 shares worth $478K. The position accounts for 0.08% of the portfolio, ranked #126.
Marino Stram & Associates first reported a position in MDT in Q4 2017 and has held it in 25 quarters since. The position peaked at $665K in Q1 2025. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Marino Stram & Associates held 6,113 shares of Medtronic worth $478K as of Q2 2026.
- Marino Stram & Associates sold 261 Medtronic shares in Q2 2026, an estimated $21.1K.
- Medtronic made up 0.08% of Marino Stram & Associates's portfolio in Q2 2026, its #126 holding.
- Marino Stram & Associates first reported a position in Medtronic in Q4 2017 and has held it in 25 quarters since.
- Marino Stram & Associates's Medtronic position peaked at $665K in Q1 2025.
- 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.